121 related articles for article (PubMed ID: 38910153)
1. A multifactorial screening model based on the Graves ophthalmopathy quality of life scores in dysthyroid optic neuropathy.
Liang JQ; Tian P; Fan SX; Zhou C; Zhou SY; Wang M; Zeng P
Graefes Arch Clin Exp Ophthalmol; 2024 Jun; ():. PubMed ID: 38910153
[TBL] [Abstract][Full Text] [Related]
2. A diagnostic model based on color vision examination for dysthyroid optic neuropathy using Hardy-Rand-Rittler color plates.
Liang J; Tian P; Wang J; Fan S; Deng X; Zhang J; Zhang J; Wang M; Zeng P
Graefes Arch Clin Exp Ophthalmol; 2023 Sep; 261(9):2669-2678. PubMed ID: 37103624
[TBL] [Abstract][Full Text] [Related]
3. Visual function changes of dysthyroid optic neuropathy and ROC curve analysis for early diagnostic indicators.
Wang S; Wang J; Chen L; Tan J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 48(8):1197-1202. PubMed ID: 37875359
[TBL] [Abstract][Full Text] [Related]
4. Combined endonasal and orbital approach for annulus of Zinn area decompression in dysthyroid optic neuropathy.
Yinghong Z; Jichao Z; Zhidi Z; Chiyu X; Haipeng Z; Yanrong R; Li Z; Yi W
Am J Otolaryngol; 2023; 44(2):103692. PubMed ID: 36473262
[TBL] [Abstract][Full Text] [Related]
5. A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy.
Kemchoknatee P; Tangon D; Srisombut T
BMC Ophthalmol; 2023 Jan; 23(1):32. PubMed ID: 36690985
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Visual Outcomes of Dysthyroid Optic Neuropathy After Surgical Orbital Decompression.
Currò N; Guastella C; Pirola G; Calonghi B; Bottari de Castello A; Fazio MC; di Benedetto S; Minorini V; Daga M; Contarino A; Muller I; Arosio M; Viola F; Pignataro L; Salvi M
Thyroid; 2023 Jun; 33(6):743-751. PubMed ID: 37140534
[No Abstract] [Full Text] [Related]
7. Comparison of surgical effect in active and inactive Dysthyroid Optic Neuropathy after Endoscopic Transnasal Medial Orbital Decompression.
Lv X; Gao Y; Ma Y; Li C; Ren Y; Zhang Z; Bao Y; Su S; Lu R
Graefes Arch Clin Exp Ophthalmol; 2024 Jan; 262(1):281-293. PubMed ID: 37530848
[TBL] [Abstract][Full Text] [Related]
8. Utility of isolated-check visual evoked potential technique in dysthyroid optic neuropathy.
Luo B; Liu R; Wang S; Hu W; Li Y; Tong B; Zhang H; Qi X
Graefes Arch Clin Exp Ophthalmol; 2023 Jul; 261(7):2031-2040. PubMed ID: 36642765
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics of dysthyroid optic neuropathy].
Elyashiv S; Skaat A; Ben Simon G; Huna-Baron R
Harefuah; 2015 Feb; 154(2):98-102, 137. PubMed ID: 25856861
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of dysthyroid optic neuropathy: combined value of orbital MRI and intracranial visual pathway diffusion kurtosis imaging.
Hu H; Zhou J; Jiang WH; Wu Q; Pu XY; Liu H; Chen HH; Xu XQ; Wu FY
Eur Radiol; 2024 Jan; ():. PubMed ID: 38276980
[TBL] [Abstract][Full Text] [Related]
11. Peripapillary and Macular Vessel Density in Dysthyroid Optic Neuropathy: An Optical Coherence Tomography Angiography Study.
Zhang T; Xiao W; Ye H; Chen R; Mao Y; Yang H
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1863-1869. PubMed ID: 31042792
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy.
Currò N; Covelli D; Vannucchi G; Campi I; Pirola G; Simonetta S; Dazzi D; Guastella C; Pignataro L; Beck-Peccoz P; Ratiglia R; Salvi M
Thyroid; 2014 May; 24(5):897-905. PubMed ID: 24417307
[TBL] [Abstract][Full Text] [Related]
13. Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy.
Deng Z; Chen L; Tan J; Wang S; Liu D; Wang J; Jiang C; Yang J; Xu B
Dis Markers; 2021; 2021():9964232. PubMed ID: 34113406
[TBL] [Abstract][Full Text] [Related]
14. Related quality of life questionnaire specific to dysthyroid ophthalmopathy evaluated in a population of patients with Graves' disease.
Delfino LC; Zunino A; Sapia V; Croome MDCS; Ilera V; Gauna AT
Arch Endocrinol Metab; 2017; 61(4):374-381. PubMed ID: 28225858
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic outcomes and influence factors of maximal orbital decompression in the treatment of severe dysthyroid optic neuropathy].
Wang Y; Li YY; Yang N; Ma R; Xiao LH
Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):416-423. PubMed ID: 28606262
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Ability of Barrett's Index and Presence of Intracranial Fat Prolapse in Dysthyroid Optic Neuropathy.
Kemchoknatee P; Chenkhumwongse A; Dheeradilok T; Srisombut T
Clin Ophthalmol; 2022; 16():2569-2578. PubMed ID: 35983164
[TBL] [Abstract][Full Text] [Related]
17. Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study.
Sears CM; Wang Y; Bailey LA; Turbin R; Subramanian PS; Douglas R; Cockerham K; Kossler AL
Am J Ophthalmol Case Rep; 2021 Sep; 23():101111. PubMed ID: 34113737
[TBL] [Abstract][Full Text] [Related]
18. Assessing the quality of life in Indian Graves' orbitopathy patients and validation of Hindi version of GO-QOL questionnaire.
Delampady K; Reddy SVB; Yadav SB
Indian J Ophthalmol; 2020 Aug; 68(8):1617-1621. PubMed ID: 32709791
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric quantitative MRI for the evaluation of dysthyroid optic neuropathy.
Zou M; Wu D; Zhu H; Huang X; Zhao X; Zhao J; Fu W; Li R; Li B; Wan P; Hong S; Li Y; Xiao H; Yang Z
Eur Radiol; 2022 Mar; 32(3):1931-1938. PubMed ID: 34642808
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of quality of life in patients with Graves orbitopathy and its influencing factors].
Weng CY; Li ZF; Hu SD; Luo YS; Feng XT; Zhong Q; Zhang Q; Shen J
Zhonghua Nei Ke Za Zhi; 2019 Aug; 58(8):577-583. PubMed ID: 31365979
[No Abstract] [Full Text] [Related]
[Next] [New Search]
